论文部分内容阅读
目的:对雷贝拉唑、奥美拉唑治疗反流性食管炎的临床疗效进行分析。方法:选取我院收治的反流性食管炎患者共116例,选取年限为2012年11月~2015年3月。随机将116例患者分成对照组以及治疗组,每组各58人。对照组通过奥美拉唑对患者进行治疗,治疗组则通过雷贝拉唑对患者进行对比治疗。结果 :治疗组中反流性食管炎患者的疗效总有效率为91.38%(53例),高于对照组的70.69%(41例),数据差异具有统计学意义(即P<0.05)。结论 :雷贝拉唑在治疗反流性食管炎上比奥美拉唑更具疗效,值得临床推广使用。
Objective: To analyze the clinical efficacy of rabeprazole and omeprazole in the treatment of reflux esophagitis. Methods: A total of 116 patients with reflux esophagitis admitted to our hospital were selected from November 2012 to March 2015. 116 patients were randomly divided into control group and treatment group, 58 in each group. Patients in the control group were treated with omeprazole, and patients in the treatment group were treated with rabeprazole. Results: The total effective rate of the treatment group was 91.38% (53 cases), which was higher than that of the control group (70.69%, 41 cases). The difference was statistically significant (P <0.05). Conclusion: Rabeprazole is more effective than omeprazole in the treatment of reflux esophagitis, which is worthy of clinical promotion.